BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang J, Wang WL, Li Q, Qiao Q. Expression of transforming growth factor-α and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World J Gastroenterol 2004; 10(6): 830-833 [PMID: 15040026 DOI: 10.3748/wjg.v10.i6.830]
URL: https://www.wjgnet.com/2218-6190/full/v10/i6/830.htm
Number Citing Articles
1
X.H. Liu, M.H. Pan, Z.F. Lu, B. Wu, Q. Rao, Z.Y. Zhou, X.J. Zhou. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinomaDigestive and Liver Disease 2008; 40(7): 560 doi: 10.1016/j.dld.2007.12.011
2
Ambreen Ayub, Usman Ali Ashfaq, Asma Haque. HBV Induced HCC: Major Risk Factors from Genetic to Molecular LevelBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/810461
3
K Breuhahn, T Longerich, P Schirmacher. Dysregulation of growth factor signaling in human hepatocellular carcinomaOncogene 2006; 25(27): 3787 doi: 10.1038/sj.onc.1209556
4
P-C Chang, C-W Chi, G-Y Chau, F-Y Li, Y-H Tsai, J-C Wu, Y-H Wu Lee. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth controlOncogene 2006; 25(14): 1991 doi: 10.1038/sj.onc.1209239
5
Masafumi Shimoda, Jack R. Wands. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 160 doi: 10.1016/B978-0-323-34062-5.00123-0
6
Karin Komposch, Maria Sibilia. EGFR Signaling in Liver DiseasesInternational Journal of Molecular Sciences 2015; 17(1): 30 doi: 10.3390/ijms17010030
7
Jen-Eing Jeng, Meng-Feng Tsai, Hey-Ru Tsai, Lea-Yea Chuang, Zu-Yau Lin, Min-Yuh Hsieh, Shinn-Chern Chen, Wan-Lung Chuang, Liang-Yen Wang, Min-Lung Yu, Chia-Yen Dai, Jung-Fa Tsai. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinomaTumor Biology 2014; 35(4): 3689 doi: 10.1007/s13277-013-1488-2
8
Ali Alqahtani, Zubair Khan, Abdurahman Alloghbi, Tamer S. Said Ahmed, Mushtaq Ashraf, Danae M. Hammouda. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted TherapiesMedicina 2019; 55(9): 526 doi: 10.3390/medicina55090526
9
Teresa Garcia-Lezana, Juan Luis Lopez-Canovas, Augusto Villanueva. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 63 doi: 10.1016/bs.acr.2020.10.002
10
Woo Sung Moon, Ho Sung Park, Ki Hoon Yu, Min Young Park, Kyung Ryoul Kim, Kyu Yun Jang, Jong Suk Kim, Baik Hwan Cho. Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesisHuman Pathology 2006; 37(10): 1324 doi: 10.1016/j.humpath.2006.04.022
11
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular CarcinomaThe Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2008; 291(6): 721 doi: 10.1002/ar.20668
12
Matthew Hennig, Michele T. Yip-Schneider, Patrick Klein, Sabrina Wentz, Jesus M. Matos, Courtney Doyle, Jennifer Choi, Huangbing Wu, Amanda O'Mara, Alex Menze, Stephen Noble, Iain H. McKillop, C. Max Schmidt. Ethanol-TGFα-MEK Signaling Promotes Growth of Human Hepatocellular CarcinomaJournal of Surgical Research 2009; 154(2): 187 doi: 10.1016/j.jss.2008.11.836
13
Y. J. Kim, H. Y. Kim, J. S. Kim, J. -H. Lee, J. -H. Yoon, C. Y. Kim, B. L. Park, H. S. Cheong, J. S. Bae, S. Kim, H. D. Shin, H. -S. Lee. Putative association of transforming growth factor-α polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infectionJournal of Viral Hepatitis 2009;  doi: 10.1111/j.1365-2893.2009.01205.x
14
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_173-1
15
Matthew Hennig, Michele T. Yip-Schneider, Sabrina Wentz, Huangbing Wu, S. K. Hekmatyar, Patrick Klein, Navin Bansal, C. Max Schmidt. Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systemsHepatology 2010; 51(4): 1218 doi: 10.1002/hep.23470
16
Masafumi Shimoda, Jack R. Wands. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract2012; : 142 doi: 10.1016/B978-1-4377-1454-8.00109-0
17
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 3159 doi: 10.1007/978-3-319-26956-6_173
18
Randa A. Zaghloul, Nehal M. Elsherbiny, Hany I. Kenawy, Amr El-Karef, Laila A. Eissa, Mamdouh M. El-Shishtawy. Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathwaysLife Sciences 2017; 185: 114 doi: 10.1016/j.lfs.2017.07.026
19
Vera Lucia Pannain, José Rodrigo Morais, Osmar Damasceno-Ribeiro, Venâncio Avancini-Alves. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissueAnnals of Hepatology 2012; 11(4): 495 doi: 10.1016/S1665-2681(19)31463-2
20
Afkar Abdel-Ghany Badawy, Ali El-Hindawi, Olfat Hammam, Mona Moussa, Samia Gabal, Noha Said. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesisAPMIS 2015; 123(10): 823 doi: 10.1111/apm.12431